Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Latest filing published 03 Jul 2025 for Pelthos Therapeutics Inc., €12.7M.
Insider track record
Disclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Ligand Pharmaceuticals Inc: trading record in brief
Ligand Pharmaceuticals Inc is a declared insider at 4 companies; the most frequent names are Viking Therapeutics, Inc., Ligand Pharmaceuticals Inc and OmniAb Operations, Inc. Over a trading history stretching from 4 August 2008 to 1 July 2025, the count stands at 10 filings.
On the market, this insider has only sold: 4 sales, €6.4M in total. Outside the open market, there are 2 share grants.
The latest filing, published on 3 July 2025, reports a transaction of €12.7M in Pelthos Therapeutics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Ligand Pharmaceuticals Inc
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
1,500,000 shares@ US$10.00Common StockSEC:0000950170-25-093589:0
16,859,308 shares0Common StockSEC:0000899243-22-035055:0
2 of 2 declarations
